Copertari N, Cordioli E, Martinelli M
Istituto di Patologia Speciale Medica e Metodologia Clinica, Università degli Studi di Bologna.
Minerva Med. 1993 May;84(5):219-25.
The present study concerns the controversial subject of rheumatoid arthritis (RA) therapy and particularly use of orally administered gold salts (auric triethylphosphine-Auranofin). It contains the results of a study conducted on 10 patients affected with RA who were treated with auric triethylphosphine associated with conventional therapy for a period varying from 4 to 8 years. The efficacy of this therapy in these patients was comparable to that observed in a survey of other studies. The authors conclude that there are advantages offered to RA patients utilizing chrysotherapy and particularly Auranofin can be administered for an extended period without the development of collateral effects in other organs or systems.
本研究关注类风湿性关节炎(RA)治疗这一颇具争议的主题,尤其涉及口服金盐(三乙膦金-金诺芬)的使用。它包含了一项针对10名类风湿性关节炎患者的研究结果,这些患者接受了三乙膦金与传统疗法联合治疗,治疗时长为4至8年。该疗法在这些患者中的疗效与其他研究调查中观察到的疗效相当。作者得出结论,对于类风湿性关节炎患者而言,采用金疗法有诸多益处,特别是金诺芬可以长期服用,而不会在其他器官或系统产生副作用。